Diabetic retinopathy.

Q4 Medicine

Ugeskrift for laeger Pub Date : 2024-09-09 DOI:10.61409/V04240246

Jakob Grauslund, Nis Andersen, Jens Andresen, Toke Bek, Sara Brandi, Javad Hajari, Søren Tang Knudsen, Caroline Schmidt Laugesen, Majbrit Lind, Mette Slot Nielsen, Katja Schielke, Yousif Subhi

引用次数: 0

Abstract

Diabetic retinopathy (DR) is the most common complication in patients with diabetes, and screening for sight-threatening end-stages is indicated to avoid severe visual loss. Screening of DR is nationally implemented in Denmark according to evidence-based national guidelines, which includes the use of individualised screening intervals. Treatment is indicated for proliferative DR and diabetic macular oedema, and treatment modalities include retinal laser therapy, intravitreal angiostatic therapy, and vitrectomy. In this review, we summarise the current guidelines for screening and treatment of DR in Denmark.

查看原文本刊更多论文

糖尿病视网膜病变。

糖尿病视网膜病变（DR）是糖尿病患者最常见的并发症，为避免严重的视力损失，必须对危及视力的终末期进行筛查。在丹麦，糖尿病视网膜病变筛查是根据以证据为基础的国家指导方针在全国范围内实施的，其中包括使用个性化的筛查间隔时间。治疗适用于增殖性 DR 和糖尿病性黄斑水肿，治疗方式包括视网膜激光疗法、玻璃体内血管静注疗法和玻璃体切除术。在这篇综述中，我们总结了丹麦目前的 DR 筛查和治疗指南。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Ugeskrift for laeger Medicine-Medicine (all)

CiteScore

0.20

自引率

0.00%

发文量

345

期刊介绍： The Ulster Medical Journal is an international general medical journal with contributions on all areas of medical and surgical specialties relevant to a general medical readership. It retains a focus on material relevant to the health of the Northern Ireland population. The Honorary Editor would welcome offers of papers for publication. Prospective authors are invited to read the notice to contributors.